These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2522594)

  • 21. Combined use of selective intracoronary thrombolysis and percutaneous transluminal coronary angioplasty for the treatment of coronary obstruction.
    Keltai M; Kádár A; Palik I; Rózsa Z
    Cor Vasa; 1984; 26(1):56-60. PubMed ID: 6233089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of conventional management and alternative therapies in limiting infarct size in acute myocardial infarction.
    Misinski M
    Heart Lung; 1987 Nov; 16(6 Pt 2):746-55. PubMed ID: 2890604
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thrombolytic treatment of acute myocardial infarct. 3].
    Gabriel HM; Soares-Costa JT; Soares-Costa TJ
    Acta Med Port; 1998 May; 11(5):431-8. PubMed ID: 9951053
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary bypass grafting after failed elective and failed emergent percutaneous angioplasty. Relative risks of emergent surgical intervention.
    Ferguson TB; Muhlbaier LH; Salai DL; Wechsler AS
    J Thorac Cardiovasc Surg; 1988 May; 95(5):761-72. PubMed ID: 2966264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with primary coronary angioplasty in management of patients suffering from acute myocardial infarction].
    Maslov LN; Krylov AL
    Angiol Sosud Khir; 2008; 14(1):131-41. PubMed ID: 19156043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.
    Mehran R; Aymong ED; Ashby DT; Fischell T; Whitworth H; Siegel R; Thomas W; Wong SC; Narasimaiah R; Lansky AJ; Leon MB
    Circulation; 2003 Sep; 108(9):1078-83. PubMed ID: 12925457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenesis of acute myocardial infarction and effectiveness of coronary thrombolysis].
    Kimata S; Hirosawa K
    Kokyu To Junkan; 1987 Apr; 35(4):361-72. PubMed ID: 2956652
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
    Steg PG; Bonnefoy E; Chabaud S; Lapostolle F; Dubien PY; Cristofini P; Leizorovicz A; Touboul P;
    Circulation; 2003 Dec; 108(23):2851-6. PubMed ID: 14623806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis during acute myocardial infarction.
    Lew AS; Ganz W
    Acute Care; 1985; 11(1):3-39. PubMed ID: 2940795
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary angioplasty as therapy for acute myocardial infarction: University of Michigan experience.
    O'Neill WW; Topol EJ; Fung A; Bourdillon PD; Nicklas JM; Walton J; Bates ER; Pitt B
    Circulation; 1987 Aug; 76(2 Pt 2):II79-87. PubMed ID: 2955959
    [No Abstract]   [Full Text] [Related]  

  • 34. [Management and long-term therapy of patients following aortocoronary bypass surgery, PTCA and thrombolysis treatment].
    Pfisterer M
    Schweiz Rundsch Med Prax; 1987 Mar; 76(10):239-40. PubMed ID: 3031797
    [No Abstract]   [Full Text] [Related]  

  • 35. [Management of acute transmural myocardial infarction: a study on 200 patients admitted to a tertiary care medical center].
    Kassab R; Rachoin JS; Azar R; Salamé E
    J Med Liban; 2005; 53(1):2-8. PubMed ID: 16398206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of medical therapy on hemorrhagic complications following coronary artery bypass grafting.
    Becker RC; Alpert JS
    Arch Intern Med; 1990 Oct; 150(10):2016-21. PubMed ID: 2222086
    [No Abstract]   [Full Text] [Related]  

  • 37. Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity.
    Garabedian HD; Gold HK
    Circulation; 1992 Mar; 85(3):1205-7. PubMed ID: 1537116
    [No Abstract]   [Full Text] [Related]  

  • 38. Preservation of cardiac function by coronary thrombolysis during acute myocardial infarction: fact or myth?
    Verani MS; Roberts R
    J Am Coll Cardiol; 1987 Aug; 10(2):470-6. PubMed ID: 2955027
    [No Abstract]   [Full Text] [Related]  

  • 39. The aggressive treatment of acute myocardial infarction.
    Braunwald E
    Circulation; 1985 Jun; 71(6):1087-92. PubMed ID: 3158451
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary angioplasty or thrombolysis for acute myocardial infarction?
    Auer J; Berent R; Weber T; Eber B
    Lancet; 2003 Mar; 361(9361):965-6; author reply 967-8. PubMed ID: 12648988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.